PDF herunterladen
Semin Reprod Med 2022; 40(05/06): 268-276
DOI: 10.1055/s-0042-1760213
Review Article

Advancing Reproductive Health through Policy-Engaged Research in Abortion Care

Sarah B. Munro 
1   Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada
,
Sheila Dunn 
2   Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada
,
Edith R. Guilbert 
3   Department of Obstetrics, Gynecology and Reproduction, Laval University, Québec City, Québec, Canada
,
Wendy V. Norman 
4   Department of Family Practice, University of British Columbia, Vancouver, British Columbia, Canada
5   Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom
› Institutsangaben Funding Canadian Institutes of Health Research (CPP-329455-107837, 2014-2024); Canadian Institutes of Health Research (PHE 148161); Michael Smith Foundation for Health Research 16743 (SBM), 18270 (SBM), 2012-5139 HSR (WVN).
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Mifepristone medication abortion was first approved in China and France more than 30 years ago and is now used in more than 60 countries worldwide. It is a highly safe and effective method that has the potential to increase population access to abortion in early pregnancy, closer to home. In both Canada and the United States, the initial regulations for distribution, prescribing, and dispensing of mifepristone were highly restricted. However, in Canada, where mifepristone was made available in 2017, most restrictions on the medication were removed in the first year of its availability. The Canadian regulation of mifepristone as a normal prescription makes access possible in community primary care through a physician or nurse practitioner prescription, which any pharmacist can dispense. In this approach, people decide when and where to take their medication. We explore how policy-maker-engaged research advanced reproductive health policy and facilitated this rapid change in Canada. We discuss the implications of these policy advances for self-management of abortion and demonstrate how in Canada patients “self-manage” components of the abortion process within a supportive health care system.

Keywords

abortion - Canada - health policy - implementation science - mifepristone


Publikationsverlauf

Artikel online veröffentlicht:
06. Februar 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA